- Home
- CHCO vs CLDX Comparison
CHCO vs CLDX Comparison
Compare CHCO & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHCO
- CLDX
- Stock Information
- Founded
- CHCO 1957
- CLDX 1983
- Country
- CHCO United States
- CLDX United States
- Employees
- CHCO N/A
- CLDX N/A
- Industry
- CHCO Major Banks
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CHCO Finance
- CLDX Health Care
- Exchange
- CHCO Nasdaq
- CLDX Nasdaq
- Market Cap
- CHCO 1.9B
- CLDX 1.8B
- IPO Year
- CHCO N/A
- CLDX 2008
- Fundamental
- Price
- CHCO $127.44
- CLDX $26.04
- Analyst Decision
- CHCO Hold
- CLDX Buy
- Analyst Count
- CHCO 4
- CLDX 8
- Target Price
- CHCO $117.25
- CLDX $64.83
- AVG Volume (30 Days)
- CHCO 50.8K
- CLDX 992.8K
- Earning Date
- CHCO 01-22-2025
- CLDX 11-06-2024
- Dividend Yield
- CHCO 2.44%
- CLDX N/A
- EPS Growth
- CHCO N/A
- CLDX N/A
- EPS
- CHCO 7.80
- CLDX N/A
- Revenue
- CHCO $289,546,000.00
- CLDX $9,976,000.00
- Revenue This Year
- CHCO N/A
- CLDX N/A
- Revenue Next Year
- CHCO $0.35
- CLDX N/A
- P/E Ratio
- CHCO $16.36
- CLDX N/A
- Revenue Growth
- CHCO 0.71
- CLDX 128.55
- 52 Week Low
- CHCO $97.50
- CLDX $22.93
- 52 Week High
- CHCO $137.28
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- CHCO 47.10
- CLDX 46.00
- Support Level
- CHCO $127.06
- CLDX $24.48
- Resistance Level
- CHCO $131.26
- CLDX $26.66
- Average True Range (ATR)
- CHCO 2.71
- CLDX 1.24
- MACD
- CHCO -0.72
- CLDX 0.04
- Stochastic Oscillator
- CHCO 17.21
- CLDX 37.41
About CHCO City Holding Company
City Holding Co is a financial holding company. It provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, saving accounts, credit card and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance, technology products, and others. These products and services are provided to commercial banking, consumer banking, mortgage banking, wealth management, and trust services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.